I agree that most fail. But you have to consider these companies were likely failing prior to the R/S (hence the need for an R/S) and were destined to fail one way or another anyway. So you must be careful saying the R/S failed. Don't get me wrong, I would not suggest an R/S if there were reason to believe an organic share price could be achieved in the near future in order to uplist. I just think the benefits of uplisting, for a company that truly has an incredible product, vastly outweigh the negative implications and connotations of a R/S.

I dont expect to change your mind or anyone elses on this matter. We have all gone around and around on this issue for a very long time. I just hope if its not being considered right now, that it will be at some point soon. The share price is very close to an "event horizon" where it will be extremely difficult to reach the $2 uplisting requirement before PRO-140 is fully developed. We are 400% away right now and have a lot of cash to raise to complete mono. Really we may have already crossed that line. Regardless, if CYDY doesn't uplist, somehow, it is forgoing significant benefits and opportunities that would make this journey so much easier.

I know there are a number of people here who would agree with you on this. But personally, I think the best thing in the world for CYDY would be to R/S and uplist, as I have said many, many, MANY times before. I am under the impression that their cash needs are immediate, so this wouldn't be helpful at this very moment but I think even within the 1st year of doing this they would see institutional money taking stakes on the open market. It would allow the big money that is interested, to invest. And ultimately performing public offerings (NO WARRANTS!) would be feasible. There will be some pain right now; I think virtually everyone has accepted that...or so says the share price anyway. But if these guys will do what should have been done years ago, I think CYDY will be able to get out of this toxic financing cycle and see some ROI.

As far as right now is concerned, there is no question in my mind they can the raise cash. Its a matter of what will the terms be. Nader did a very good job negotiating the past several raises with Paulson, in my opinion. But it appears that avenue is now closed. I cant assume anything as far as what their cash needs will be to get adjunct done. But one way or another I dont think this next raise will be large. Maybe $3-5 million. It will be interesting to see how it plays out.

After this was stated a few weeks back I didnt hear much commentary at all, from either bull or bear on this board, which I thought was odd. In my mind this could have a lot of implications. And obviously the result could shape the near term share price, barring any surprises. This is neither here nor there to me as I dont have a position but I would like to hear any opinions from the board on this matter, if there are any.

Man, is this getting the "Israeli Discount" or what? How is this so cheap??? Yeah I could use some great timing right now. I got hosed in CYDY. What a f#$@ing disaster that has turned out to be. Anyway, this is looking like a real good place to let my money sit and regain its former value.

Looks like a great place to take a long position. Im in!

Thank you Misiu. I have always appreciated your DD as well. Yes I am sorry to leave also but sometimes investments dont work out as planned. I wish you the best as well and hopefully some day I will be back to CYDY.

Yea we have had a few good rallies on technicals in the past. I will definitely keep an eye on it. If I buy back it will likely just be for a swing trade unless there are some major changes/developments. Are there any other indicators that have shown consistency with CYDY?

There are some challenges here but I believe that it will also. And risk management is key to successful investing. I had to close out my position entirely but part of the reason for that was my over exposure. I bet big that combo would be complete by now, along with other milestones and that we would be well on our way to mono completion. I lost that bet. Its like anything else, know when to fold em. I will be watching CYDY and will jump back in if the timing and price is right. I wish you the best here and with your other investments.

Thank you BH, likewise. And the same to you and all other longs on this board.

Thank you Boom, thats very kind of you and the feeling is mutual. Yes it is difficult to see the future right now. But imo, the dust will settle and I think PRO-140 will be approved eventually. Im not sure how everything will pan out for shareholders exactly but I do think it will get there. For now lets hope they are close to completing combo.

Yea I was (and am still) very disappointed. Its most frustrating to accept due to the potential that exists for PRO-140. But there were other factors that outweighed that (for me). So live and learn. I did learn a lot.

If it makes you feel any better I lost an enormous amount of money here also. My average was over $1.00. But after the last CC I had to cut my losses. It was really difficult to accept the loss but an easy decision to sell. It will probably take a while to recover but thats the way it goes sometimes.

Here are the exhibits if you would like to read through them. The omitted portions are marked with an asterisk. Looks like they are just keeping their contract pricing under wraps.

http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11995353-142904-246717&type=sect&TabIndex=2&companyid=113426&ppu=%252fdefault.aspx%253fcik%253d1175680

http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11995353-246838-264953&type=sect&TabIndex=2&companyid=113426&ppu=%252fdefault.aspx%253fcik%253d1175680

I agree.

To my knowledge the most recent manufacturing agreement is with these guys (CMC Biologics). And that was announced back in February.

Not sure about previous CT orders. But this is in regards to certain information in exhibits 10.4 and 10.5.

Read the exhibits.

You can find out what its about right now. Just read the 10-Q.

Hahaha, thats a Freudian slip if ive ever seen one. Or is that Pears new moniker? Thanks for the laugh!

Well, if they had the cash at the time (and at this rate maybe even if they didnt have the cash) it would have been far better to push mono and put combo on the back burner, IMO. But of course hind sight is 20/20. I dont think anyone in their wildest dreams imagined combo could take so long. If you look at ------>

https://clinicaltrials.gov/archive/NCT02483078/2015_06_25

the first estimates were back in July of 2015 and primary endpoints were anticipated for completion, 300 patients by December of 2015. And here we are almost 2 years later with less than 30 patients enrolled.

Anyway at this point I think changing gears would be a mistake. Just get it done and don't ever run another combo trial again. This is a pivotal trial so it should be able to be used for approval.

Yea, who knows at this point. I really think data will be good but when will that be? They didn't give an enrollment update in the CC. In my opinion, 2nd quarter this year might as well be 2nd quarter next year. Im sorry to say, its a meaningless estimate to me. Not just because there have been so many of them that have come and gone but because it appears to be sincerely challenging to accurately predict. However once they complete that should give them a boost and hopefully they can get a solid offering price in to fund mono. And really I think Paulson has been good for whats available to a micro-cap OTC company. Aside from having to offer at such a low price, its the warrants that have really been the biggest drag on growth. It will be interesting to see what price they will be able to negotiate this next raise at. Nader has done a pretty good job at getting the offerings placed at 0.75, even when s/p was a few cents lower. Now its hard to say.

I think the issue is related to funding. Obviously they need to raise the cash to fund the trial, which will be vastly more expensive than combo. And I think in order to raise the cash, at a reasonable valuation at least, they need to complete combo. So its kind of a catch 22 at this point as they are obviously having issues with enrollment. Now it looks like there will be further cash needing to be raised to complete the combo trial.

If we get good news tomorrow then I would expect that 0.70 wall will disappear real quick with some volume. In my opinion it is likely someone from the last raise hedging their bet. The fact that the s/p continues to pin 0.70 is likely an indicator there is some knowledge or strong expectations of very bullish news on tap for tomorrow. GL2U

WHAT?! You think CYDY is going to need to issue a stock offering to fund trials?!?! Oh my goodness, say it isn't so!!!............. (-_-)

After reviewing the 10-Q, it appears the $7.8 mil cash does include the end of February raise. The O/S from the 10-Q is 149.46mil

http://ir.cytodyn.com/all-sec-filings?page=1#document-16757-0001193125-17-123300

and the O/S immediately following the Feb raise is 149.46mil

https://www.sec.gov/Archives/edgar/data/1175680/000119312517060264/d326846d424b5.htm

80% is hardly a lotto ticket man, especially when trading a micro cap. There are plenty of things that could pop this to 1.25 in a blink. Unfortunately I dont think those odds are likely with this CC. I would love to be wrong but it would have to be something out of left field, imo.

If I have to listen to one more CC about how exciting the future is for CYDY and tears of the patients and the patting each other on the back and we have our work cut out for us, without hearing of any substantial progress I might just sell my positions, take my losses and walk. We'll see what Dr.P has for us but if its more of the same I am gone. All I want to know is what has been accomplished and what milestones have been reached. Thats it.

Just skimmed over 10-Q. $7.8 mil cash and I have to assume that does not include the $3 mil + from the last offering.

And they are saying adjunct enrollment to be completed in Q2 now...smh. What a joke.

No offense but you really need to learn how to read SEC filings before spouting out nonsense like that.

Wow. Moving up with some big volume starting to come in. Hmmm, wonder if someone knows something here.

Well dont be surprised because I dont think there is literally A SINGLE PERSON on this board who is "buying into the Sheikh" or whatever. In fact the ONLY people on the board who ever talk about him are the bears, trying to mock the bulls??? i guess... like some unknown internet personality is part of eveyones investment thesis? Im not really sure, havent wasted the time trying to figure it out.

Anyway, when this Sheikh name first hit the scene there was some discussion since he apparently had a pretty good record of picking winners. But thats it. Maybe he's lucky, maybe he's good or maybe he's not. One way or another no one is going to drop serious cash on an investment without knowing what they are buying first.

Yep im still around, and still long all my shares. But I dont post much anymore so I felt it would be best to give my mod spot to someone more active.

Im not happy at all with this latest delay. Management has absolutely destroyed shareholder confidence and the s/p clearly reflects it. Either the next CC will announce primary endpoints for adjunct or these guys are going to be looking for new jobs come August.

That aside, CYDY has all the potential it had last week, last month, last year and PRO-140 is further developed. A 10-20 bagger easy. Im interested to see exactly what Anthony has been working on "day and night". Its very possible he is working on a "hail Mary" after this delay and will announce a partnership or something equally redeeming.

Its hard for me to believe insider transactions are being debated here. It takes less than 5 mins to verify, and thats reading through the filings! Anyway here is the NASDAQ link for those that apparently just started investing yesterday.

http://www.nasdaq.com/symbol/cydy/insider-trades

I suggest you read the SEC filings before you embarrass yourself further.

Seen it a thousand times. SMH, most people never learn. People scrambling to sell at lows should really take a minute to THINK about what their investment strategy is.

This says it all about your typical retail investor:

http://i.investopedia.com/content/advisor_article/8_common_biases_that/image001.jpeg

And why most people trade for a few years and give up after losing a substantial amount of their initial net worth.

Thanks to whoever sold those blocks in the 0.60's. Its buy low sell high, not the other way around ;)

I dont think PRO-140 is being perceived as anything at all. It is starting to gain some visibility in the scientific community but at the same time managing to remain virtually invisible in the investment community. And other treatments are always being developed for HIV. They have been coming and going for decades now. More oral HAART pills? More of the same...drugs. Look no further than the organic food movement and you will see that we live in a society that puts a huge valuation on "healthy living". And I dont think it needs to be said that people living with HIV put an even greater valuation on health. Not taking any other selling points into consideration, offering the first biologic (as opposed to chemical ie HAART) treatment will go a very long distance with sales imo. Im not saying I have no disappointments with CYDY but PRO-140 and its future prospects are certainly not one of them. And with our MC under $100m, even just taking a sliver of the $16b market multiplied by the average P/E, gives CYDY a huge amount of room to grow. Good luck to you. Im keeping my bets here.

I have to agree. And I dont know why there seems to be so much shock over this most recent dip in S/P. Nothing has changed. Data at CROI was good but no revelations. CYDY needs to show progression in their trials. The "market", and I still firmly maintain that OTC is NOT the market, wants to see substance, not presentations on mostly known data. Dont get me wrong, presentations are always good but unless you are unveiling new data they dont usually move s/p. Anyway I dont know why all the bearish sentiment lately. We are still expecting news on BTD and primary endpoints for adjunct by the end of this month. This pull back just seems like a good buying opportunity, imo.

What is all this talk about making decisions to leave or stick around? Did I miss something??? Last I checked there haven't been any significant PR's or catalysts....which was NOT unexpected. We have several large milestones coming in the next weeks and the chart is trending up. Nothing has changed, aside from some good data at CROI, yet there is a lot of negativity and raw emotions on the board. What am I missing?

Pears, you seem very hung up on this. You can have viral rebound without resistance. Thats the difference. Resistance can be observed and measured. In the patients taking PRO-140 that showed viral rebound they did not show any resistance to the antibody. Thats why there is support from the FDA to increase the dosage in patients that exhibit this marker. Does that make sense?